TNGX · Forms 3, 4, 5
Insider trades at Tango Therapeutics, Inc.
2 insiders sold $859K of Tango Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Tango Therapeutics, Inc. (TNGX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Adam Crystal | President, R&D | Option exercise | 27,000 | $5.20 | $140K | Form 4 | |
| Adam Crystal | President, R&D | Sell (10b5-1 plan) | 26,400 | $24.45 | $646K | Form 4 | |
| Adam Crystal | President, R&D | Sell (10b5-1 plan) | 600 | $25.32 | $15K | Form 4 | |
| Jessica Newcomb | Principal Accounting Officer | Sell (10b5-1 plan) | 700 | $22.80 | $16K | Form 4 | |
| Jessica Newcomb | Principal Accounting Officer | Sell (10b5-1 plan) | 5,100 | $23.97 | $122K | Form 4 | |
| Jessica Newcomb | Principal Accounting Officer | Sell (10b5-1 plan) | 2,400 | $25.17 | $60K | Form 4 | |
| Adam Crystal | President, R&D | Option exercise | 27,000 | $5.20 | $140K | Form 4 | |
| Adam Crystal | President, R&D | Sell (10b5-1 plan) | 27,000 | $22.37 | $604K | Form 4 | |
| Adam Crystal | President, R&D | Option exercise | 27,000 | $5.20 | $140K | Form 4 | |
| Adam Crystal | President, R&D | Sell (10b5-1 plan) | 5,267 | $26.79 | $141K | Form 4 | |
| Adam Crystal | President, R&D | Sell (10b5-1 plan) | 21,733 | $27.35 | $594K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.